GB202308366D0 - Hybridoma cell strain 9C1, PLGF-1 monoclonal antibody, preparation method therefor and application thereof - Google Patents

Hybridoma cell strain 9C1, PLGF-1 monoclonal antibody, preparation method therefor and application thereof

Info

Publication number
GB202308366D0
GB202308366D0 GBGB2308366.0A GB202308366A GB202308366D0 GB 202308366 D0 GB202308366 D0 GB 202308366D0 GB 202308366 A GB202308366 A GB 202308366A GB 202308366 D0 GB202308366 D0 GB 202308366D0
Authority
GB
United Kingdom
Prior art keywords
plgf
preparation
application
monoclonal antibody
method therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2308366.0A
Other versions
GB2616177A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Aucheer Biotechnology Co Ltd
Original Assignee
Ningbo Aucheer Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo Aucheer Biotechnology Co Ltd filed Critical Ningbo Aucheer Biotechnology Co Ltd
Publication of GB202308366D0 publication Critical patent/GB202308366D0/en
Publication of GB2616177A publication Critical patent/GB2616177A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GB2308366.0A 2020-11-10 2020-11-10 Hybridoma cell strain 9C1, PLGF-1 monoclonal antibody, preparation method therefor and application thereof Pending GB2616177A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2020/127828 WO2022099465A1 (en) 2020-11-10 2020-11-10 Hybridoma cell strain 9c1, plgf-1 monoclonal antibody, preparation method therefor and application thereof

Publications (2)

Publication Number Publication Date
GB202308366D0 true GB202308366D0 (en) 2023-07-19
GB2616177A GB2616177A (en) 2023-08-30

Family

ID=81601865

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2308366.0A Pending GB2616177A (en) 2020-11-10 2020-11-10 Hybridoma cell strain 9C1, PLGF-1 monoclonal antibody, preparation method therefor and application thereof

Country Status (2)

Country Link
GB (1) GB2616177A (en)
WO (1) WO2022099465A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114874318B (en) * 2022-06-13 2023-06-02 复旦大学附属中山医院 NG-2 immunohistochemical antibody
CN115261331B (en) * 2022-07-07 2024-05-10 河南省农业科学院 Monoclonal antibody of anti-PEDV S protein and application thereof
CN115584346A (en) * 2022-10-08 2023-01-10 厦门大学 Mouse anti-human STC2 monoclonal antibody hybridoma cell strain, monoclonal antibody, preparation and application thereof
CN116732045A (en) * 2023-07-13 2023-09-12 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) Anti-cat IgG monoclonal antibody and application thereof
CN117230020B (en) * 2023-11-14 2024-01-26 中国农业科学院生物技术研究所 G10 EPSPS monoclonal antibody hybridoma cell strain, antibody produced by same and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2601267C (en) * 2005-03-24 2014-02-18 Thromb-X N.V. Novel anti-plgf antibody
US8741287B2 (en) * 2008-06-18 2014-06-03 Abbott Laboratories PlGF-1 assay and kits and components thereof
EP2300825A4 (en) * 2008-06-18 2012-04-25 Abbott Lab P/gf-1 companion diagnostic methods and products
CN102219854A (en) * 2010-04-15 2011-10-19 苏州思坦维生物技术有限责任公司 Monoclonal antibody of anti-human PIGF (placental growth factor) protein as well as preparation method and application thereof

Also Published As

Publication number Publication date
GB2616177A (en) 2023-08-30
WO2022099465A1 (en) 2022-05-19

Similar Documents

Publication Publication Date Title
GB202308366D0 (en) Hybridoma cell strain 9C1, PLGF-1 monoclonal antibody, preparation method therefor and application thereof
EP4170021A4 (en) Mouse anti-mcr-1 protein hybridoma cell strain, monoclonal antibody, and application
EP4063498A4 (en) Anti-oxa-23 type carbapenase hybridoma cell line, monoclonal antibody, and application
EP4089115A4 (en) Anti-tigit antibodies and usage method
EP4063497C0 (en) Anti-imp type carbapenemase hybridoma cell strain, monoclonal antibody and use
EP4112722C0 (en) Anti-vim carbapenemase hybridoma cell strain, monoclonal antibody, and application
EP4265717A4 (en) Mouse anti-mcr-1/mcr-2 protein hybridoma cell strain, monoclonal antibody and use
EP4148066A4 (en) T cell antigen receptor, multimeric complex thereof, and preparation method therefor and use thereof
EP3940076A4 (en) Robo1 car-nk cell carrying suicide gene, preparation method therefor and application thereof
EP4067385A4 (en) Monoclonal antibody for detection of car-t cells, kit and application
EP4112723A4 (en) Anti-kpc type carbapenemase hybridoma cell line, monoclonal antibody and application thereof
EP3919512A4 (en) HUMANIZED ANTI-Abeta MONOCLONAL ANTIBODY AND APPLICATION THEREOF
MX2022011951A (en) Antibodies binding siglec15 and uses thereof.
EP4083068A4 (en) Anti-ngf antibody and antigen-binding fragment thereof, preparation method thererofr, and application thereof
EP4108684A4 (en) Antibody binding to tigit antigen, preparation method therefor and use thereof
EP4163297A4 (en) T cell antigen receptor, multimeric complex thereof and preparation method and use thereof
EP3967711A4 (en) Tetravalent bispecific antibody, preparation method therefor, and use thereof
EP4074733A4 (en) Immunoglobulin binding protein, preparation method and application thereof
MX2022010665A (en) Antibodies binding il4r and uses thereof.
EP4261278A4 (en) Mouse anti-ndm carbapenemase hybridoma cell strain, monoclonal antibody and use
EP4261227A4 (en) Mouse anti-oxa-48 carbapenemase hybridoma cell strain, monoclonal antibody and use
EP3991744A4 (en) Anti-cd47/anti-tigit bispecific antibody, preparation method therefor and application thereof
TWI799855B (en) NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-CoV-2 AND USES THEREOF
EP4095154A4 (en) Method for improving antibody affinity with antigen, and use thereof
EP3988564A4 (en) Leptin immunogen, hybridoma cell, monoclonal antibody, polyclonal antibody and use thereof

Legal Events

Date Code Title Description
789A Request for publication of translation (sect. 89(a)/1977)

Ref document number: 2022099465

Country of ref document: WO